Institute of Forensic Medicine, University Hospital Bonn, Stiftsplatz 12, Bonn 53111, Germany.
Institute of Forensic Medicine, University Hospital Mainz, Am Pulverturm 3, Mainz 55131, Germany.
J Anal Toxicol. 2022 May 20;46(5):519-527. doi: 10.1093/jat/bkab042.
The interpretation of postmortem γ-hydroxybutyric acid (GHB) concentrations is challenging due to endogenous existence and postmortem GHB production in body tissues and fluids. As an additional complication, formation of GHB was also described in stored postmortem samples. We examined cardiac blood, femoral blood, vitreous humor, cerebrospinal fluid and urine of eight different corpses (male/female 5/3, aged 33-92 years, postmortem interval 1-6 days) where no intake of GHB or one of its precursors was assumed. All samples were collected during autopsy and divided into two aliquots. To one of the aliquots, sodium fluoride (NaF, 1% w/v) was added. Both aliquots were vortexed, further divided into seven aliquots and stored at -20°C. GHB concentrations were measured immediately and subsequently 1 day, 7 days, 2 weeks, 4 weeks, 3 months and 6 months, after sample collection using trimethylsilyl derivatization and gas chromatography, coupled to single quadrupole mass spectrometry. Similar progression curves of GHB concentrations were obtained for the different matrices in the individual corpses. Femoral and cardiac blood GHB concentrations were always found to be higher than in vitreous humor, cerebrospinal fluid, and urine irrespective of stabilization and storage time. None of the obtained GHB concentrations exceed the cutoff values for postmortem matrices commonly used for the identification of an exogenous GHB intake (urine, venous blood and cerebrospinal fluid: 30 mg/L, cardiac blood and vitreous humor 50 mg/L). No significant differences were found for the GHB concentrations measured immediately and 6 months after autopsy. However, we found a significant increase for the GHB concentrations 4 weeks as well as 3 months after sample collection, which was followed by a decrease nearly to initial values. There were no significant differences between samples with and without NaF addition. The data presented are useful for the interpretation of GHB concentrations in upcoming death cases, with special attention to storage conditions and different postmortem matrices.
由于内源性存在以及死后组织和体液中 GHB 的产生,死后 GHB 浓度的解读具有挑战性。作为一个额外的复杂因素,存储的死后样本中也描述了 GHB 的形成。我们检查了 8 具不同尸体的心血、股血、玻璃体、脑脊液和尿液(男/女 5/3,年龄 33-92 岁,死后间隔 1-6 天),假设这些尸体没有摄入 GHB 或其前体之一。所有样本均在尸检时采集,并分为两份。一份加入氟化钠(NaF,1%w/v)。将两份样本涡旋混合,进一步分为 7 份,储存在-20°C。立即测量 GHB 浓度,随后在采样后 1 天、7 天、2 周、4 周、3 个月和 6 个月时使用三甲基硅烷基衍生化和气相色谱法,结合单四极杆质谱法进行测量。在个体尸体的不同基质中,获得了相似的 GHB 浓度进展曲线。无论稳定化和储存时间如何,股血和心血中的 GHB 浓度总是高于玻璃体、脑脊液和尿液中的 GHB 浓度。在所获得的 GHB 浓度中,没有任何一种超过常用于鉴定外源性 GHB 摄入的死后基质的截止值(尿液、静脉血和脑脊液:30mg/L,心血和玻璃体:50mg/L)。尸检后立即和 6 个月测量的 GHB 浓度无显著差异。然而,我们发现样本采集后 4 周和 3 个月时 GHB 浓度显著增加,随后几乎降至初始值。有和没有 NaF 加标的样本之间没有显著差异。所提供的数据对于解读即将到来的死亡案例中的 GHB 浓度非常有用,特别要注意储存条件和不同的死后基质。